2m 2m 2m 2m 2m 2m 2m
NUVALENT-A (NUVL)
NASDAQ
$123.92-$0.02 (-0.02%)
Price as of Jul 13, 2026 7:47 PM EDT- $9.1BMarket Cap
- 46.52%1-Year Change
- BiotechnologyIndustry
NUVALENT-A (NUVL)
$123.92-$0.02 (-0.02%)
NUVL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $123.94 | ||
Change | +$0.04 (+0.03%) | ||
Open | $123.88 | ||
High | $123.97 | ||
Low | $123.87 | ||
Previous Close | $123.90 | ||
Volume | 2,458,548 | ||
30-Day Average Volume | 2,147,894 | ||
1-Week Change | 0.18% | ||
1-Month Change | 0.56% | ||
1-Year Change | 46.52% | ||
3-Year Change | 195.52% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.7M | ||
Total Assets | $1.3B | ||
Market Cap | $9.1B | ||
Enterprise Value | $9.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$109.3M | ||
Free Cash Flow | -$92.4M | ||
EBIT | -$109.1M | ||
EBITDA | -$109.1M | ||
Net Working Capital | $1.2B | ||
EPS | -$1.39 | ||
Enterprise Value/EBITDA | -82 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -89 | ||
PEG | -7 | ||
Price/Free Cash Flow | -99 | ||
Price/Operating Cash Flow | -99 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1200000 | ||
Last Split Date | 03/10/2017 | ||
Earnings & Revenue